Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04555902 · ClinicalTrials.gov registry record · NA

Evaluation of Mailers Promoting Mammogram Screening

A NA study of Breast Cancer, sponsored by Geisinger Clinic.

Completed
Registry status
NA
Development phase
1,342
Enrollment target
1
Study location

NCT04555902 is a NA study of Breast Cancer that has completed, run by Geisinger Clinic. The registered enrollment target is 1,342 participants, below the 2,802-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (52% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04555902, a NA study of Breast Cancer, has completed, sponsored by Geisinger Clinic.

COMPLETED
Registry status
NA
Development phase
1,342 participants
Enrollment target
1
Study location

Study Summary

In this evaluation, 3 different versions of mailers promoting annual mammograms are being sent to women on the month of their 50th and 64th birthdays. The researchers hypothesize that the use of behavioral nudges in the mailers should lead to increased uptake in mammogram screening.

Conditions Studied

Interventions

  • BEHAVIORAL Postcard
  • BEHAVIORAL Small Gift
  • BEHAVIORAL Loss Frame and Fear Appeals

Study Locations (1)

Pennsylvania

  • Geisinger - Danville

Trial Details

FieldValue
Enrollment Target 1,342 participants
Start Date 2020-10-02
Est. Completion 2021-10-05
Phase NA

Sponsor

Geisinger Clinic

107 total trials

What the Registry Record Tells You About NCT04555902

The ClinicalTrials.gov registry entry for NCT04555902 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,342 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,802-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (52% lower). The listed sponsor is Geisinger Clinic, which has 107 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 3 interventions - of which Postcard is the first listed.

NCT04555902 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT04555902 about?

NCT04555902 is a clinical study titled "Evaluation of Mailers Promoting Mammogram Screening". In this evaluation, 3 different versions of mailers promoting annual mammograms are being sent to women on the month of their 50th and 64th birthdays. The researchers hypothesize that the use of behavioral nudges in the mailers should lead to increased uptake in mammogram screening.

What is the current status of trial NCT04555902?

This trial is currently completed. It is a NA study. The enrollment target is 1,342 participants. The study started on 2020-10-02. Estimated completion is 2021-10-05.

What conditions does trial NCT04555902 study?

This clinical trial studies the following conditions: Breast Cancer.

What interventions are being tested in trial NCT04555902?

The interventions under investigation include: Postcard (BEHAVIORAL), Small Gift (BEHAVIORAL), Loss Frame and Fear Appeals (BEHAVIORAL).

Who is sponsoring clinical trial NCT04555902?

This trial is sponsored by Geisinger Clinic, which has 107 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04555902 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.